Loading...
Melatonin and Nitrones As Potential Therapeutic Agents for Stroke
Stroke is a disease of aging affecting millions of people worldwide, and recombinant tissue-type plasminogen activator (r-tPA) is the only treatment approved. However, r-tPA has a low therapeutic window and secondary effects which limit its beneficial outcome, urging thus the search for new more eff...
Saved in:
Published in: | Front Aging Neurosci |
---|---|
Main Authors: | , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Frontiers Media S.A.
2016
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5120103/ https://ncbi.nlm.nih.gov/pubmed/27932976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2016.00281 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|